Kenneth Gorelick - NextTrip Director
| NTRP Stock | USD 2.77 0.20 6.73% |
Director
Dr. Kenneth J. Gorelick is Director of the Company. Dr. Gorelick is the Managing Director of Zymo Consulting Group LLC, that provides consulting services to the biopharmaceutical industry, specializing in clinical development and regulatory affairs. He currently serves as Chair of the Program Advisory Board for Asahi Kasei Pharma America and as Chief Medical Officer for PIN Pharma, among others since 2016.
| Tenure | 8 years |
| Professional Marks | Ph.D |
| Address | 1560 Sawgrass Corporate Parkway, Sunrise, FL, United States, 33323 |
| Phone | 888 444 5555 |
| Web | https://www.nexttrip.com |
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Peter Bisson | Gartner | 63 | |
| Eden Woon | VNET Group DRC | N/A | |
| Anne Minto | ExlService Holdings | 64 | |
| David Kelso | ExlService Holdings | 65 | |
| Nitin Sahney | ExlService Holdings | 55 | |
| Jill Smart | EPAM Systems | 60 | |
| Michael McMahon | Fiserv Inc | 72 | |
| Melanie Trent | Fiserv Inc | 55 | |
| Robert Drummond | Fiserv Inc | 59 | |
| Todd Correll | Data Storage Corp | 47 | |
| Yao Li | VNET Group DRC | 49 | |
| Eileen Serra | Gartner | 65 | |
| William Berry | Fiserv Inc | 67 | |
| Deborah Kerr | ExlService Holdings | 46 | |
| Terry Wang | VNET Group DRC | 55 | |
| Sheldon Erikson | Fiserv Inc | 73 | |
| Ajay Agrawal | Genpact Limited | 51 | |
| Mark Verdi | Genpact Limited | 54 | |
| Brian Stevens | Genpact Limited | 57 | |
| Richard Mayoras | EPAM Systems | 57 | |
| Raul Cesan | Gartner | 72 | |
NextTrip Leadership Team
Elected by the shareholders, the NextTrip's board of directors comprises two types of representatives: NextTrip inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NextTrip. The board's role is to monitor NextTrip's management team and ensure that shareholders' interests are well served. NextTrip's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NextTrip's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan Schechter, Director | ||
| Bruce Bernstein, Director | ||
| David Crockford, VP of Regulatory Affairs of Neurotrope Bioscience | ||
| Amy Proost, Chief Officer | ||
| Joshua Silverman, Chairman of the Board | ||
| Michael Ciraolo, COO, General Counsel | ||
| Kenneth Gorelick, Director | ||
| Andrew Perlman, Director | ||
| Susanne Wilke, Director | ||
| William Kerby, CEO Founder | ||
| William Singer, Secretary, Director | ||
| Paula Trzepacz, Executive Vice President and Chief Medical Officer | ||
| James Gottlieb, Director | ||
| Elaine Grenier, Director of Clinical Operations of Neurotrope Bioscience | ||
| Rama Marupilla, Chief Officer | ||
| Paul Freiman, Chairman of the Board | ||
| Daniel Alkon, President Chief Scientific Officer | ||
| Gregory CPA, Chief Officer | ||
| Ivan Gergel, Director | ||
| Charles Ramat, CEO and President and Director | ||
| Richard Marshall, Director Development | ||
| Jay Haft, Director | ||
| Shana Phares, Director | ||
| Lyndsey North, President | ||
| Larry Altstiel, Director | ||
| Robert Weinstein, CFO, Executive VP, Treasurer and Secretary | ||
| Charles Ryan, Director |
NextTrip Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NextTrip a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | (1.55) X | ||||
| Revenue | 630.43 K | ||||
| EBITDA | (8.55 M) | ||||
| Net Income | (8.69 M) | ||||
| Cash And Equivalents | 27 M | ||||
| Cash Per Share | 1.13 X | ||||
| Debt To Equity | (546.81) % | ||||
| Current Ratio | 22.40 X | ||||
| Book Value Per Share | 1.17 X | ||||
| Cash Flow From Operations | (8.21 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NextTrip in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NextTrip's short interest history, or implied volatility extrapolated from NextTrip options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NextTrip. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NextTrip Stock, please use our How to Invest in NextTrip guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for NextTrip Stock analysis
When running NextTrip's price analysis, check to measure NextTrip's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextTrip is operating at the current time. Most of NextTrip's value examination focuses on studying past and present price action to predict the probability of NextTrip's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextTrip's price. Additionally, you may evaluate how the addition of NextTrip to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is NextTrip's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NextTrip. If investors know NextTrip will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NextTrip listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NextTrip is measured differently than its book value, which is the value of NextTrip that is recorded on the company's balance sheet. Investors also form their own opinion of NextTrip's value that differs from its market value or its book value, called intrinsic value, which is NextTrip's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NextTrip's market value can be influenced by many factors that don't directly affect NextTrip's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NextTrip's value and its price as these two are different measures arrived at by different means. Investors typically determine if NextTrip is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NextTrip's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.